Recent immunohistochemical studies including ours showed that PI3K/AKT is constitutively activated in human esophageal tumor tissues [10], but studies that evaluate PI3K/AKT signaling based on matched tumor and normal tissues are limited. This evidence concerns the gene AKT1 and neoplasm.